⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer

Official Title: A Phase 2, Randomized, Proof-of-Concept Study of Nab-Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Previously Untreated Metastatic Pancreatic Cancer

Study ID: NCT02570711

Study Description

Brief Summary: To evaluate the safety and efficacy of ACP-196 and nab paclitaxel/gemcitabine in subjects with previously untreated metastatic pancreatic cancer using standard response criteria

Detailed Description: A Phase 2, multicenter, open-label, randomized clinical trial. The study was to evaluate the efficacy and safety of ACP-196 plus nab-paclitaxel/gemcitabine compared with nab-paclitaxel/gemcitabine in subjects who have previously untreated metastatic pancreatic cancer.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Ventura Clinical Trials, Ventura, California, United States

Florida Cancer Specialists, Fort Myers, Florida, United States

Duke University Medical Center, Durham, North Carolina, United States

Oncology Hematology Care, Cincinnati, Ohio, United States

Cleveland Clinic, Cleveland, Ohio, United States

Tennessee Oncology, Chattanooga, Tennessee, United States

Tennessee Oncology, Nashville, Tennessee, United States

The Center for Cancer and Blood Disorders, Fort Worth, Texas, United States

MD Anderson Cancer Center, Houston, Texas, United States

International Cancer Center, Houston, Texas, United States

Contact Details

Name: Acerta Clinical Trial

Affiliation: 1-888-292-9613; acertamc@dlss.com

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: